About the IBC
The role of the Institutional Biosafety Committee (IBC) is to provide advice and recommendations to the Colgate community by reviewing protocols and approving procedures that will provide for the safe conduct of teaching and research while ensuring compliance with government requirements regarding the use of biological materials. Members of the IBC are selected for their area of expertise, and the committee includes members from the surrounding community. The IBC will meet once every semester to review protocols, and in the intervening time the IBC chair will consult with members to address questions generated from any new protocols.
The IBC can approve or disapprove protocols, make recommendations for corrective action for protocols, and facilitate development of appropriate protocols; if it is not possible to comply with regulations, the IBC will stop further teaching or research. The committee is the link between Colgate University and regulatory agencies, and reports as required to regulatory agencies.
All teaching and research with biological materials must have protocols registered with the IBC for approval and review. The includes the use of transgenic organisms, recombinant DNA, human blood or tissues, or other potentially biohazardous materials. The IBC has an overlapping role with other committees, i.e., Institutional Review Board and the Institutional Animal Care and Use Committee, and will communicate with them as necessary and appropriate.